Oxford immunotec global plc (OXFD)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash flows from operating activities
Net loss

-6,340

-1,809

140,871

136,670

129,609

120,779

-11,481

-24,844

-35,139

-32,885

-46,543

-33,692

-23,372

-22,349

-23,881

-24,368

-25,216

-24,478

-24,780

-26,392

-25,332

-22,174

-18,810

-15,896

-10,616

-8,664

0

0

0

Less: Net loss from discontinued operations, net of tax

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss from continuing operations

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Less: Net income (loss) from discontinued operations, net of tax

-

-

-

-

-

108,274

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net income (loss) from continuing operations

-

-

-

-

-

12,505

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustments to reconcile net loss from continuing operations to net cash used in operating activities:
Depreciation and amortization expense

1,749

1,753

2,060

1,905

1,791

1,662

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Provision for inventory

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash rent expense

236

247

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization of intangible assets

-

-

-

-

-

-

-

-

-

-

0

0

3,516

-

2,676

2,411

2,270

2,142

2,036

1,918

1,844

1,742

1,477

1,304

1,157

1,101

0

0

0

Change in fair value of contingent purchase price consideration

-

-

-

-

-

-

-

-

-

-3,475

-4,855

-3,915

-3,620

-1,208

226

218

210

202

0

0

0

-

-

-

-

-

-

-

-

Accretion and amortization of loan fees

-

-

-

-

-

-

-

-

560

569

0

0

149

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Share-based compensation expense

3,725

3,613

3,631

3,595

3,592

4,507

5,092

5,514

6,105

5,671

5,203

5,202

5,123

4,901

4,730

4,356

3,714

3,485

3,344

3,084

3,131

2,521

1,822

1,140

393

140

0

0

0

Loss on change in fair value of warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22

0

0

0

-

-

-

-

Loss on disposal of property and equipment

-

-

-

-

-

-115

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income taxes

154

-38

0

0

0

-

-

-

-

1,602

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, net

3,457

4,263

8,785

7,099

3,975

3,390

-1,379

-2,506

-2,270

988

-3,359

3,025

3,759

1,642

8,354

2,713

1,245

416

2,552

2,907

-890

2,311

-1,945

-2,332

2,958

-637

0

0

0

Inventory, net

1,558

2,826

4,134

3,512

2,732

1,015

508

-260

1,266

1,768

1,191

1,207

802

1,486

1,513

3,911

2,840

893

264

-861

245

1,214

2,531

3,527

3,279

2,808

0

0

0

Prepaid expenses and other assets

-2,634

-1,386

1,497

-207

449

-207

302

920

109

454

4,662

4,332

4,597

3,063

-267

-857

-963

898

697

1,017

722

594

-1,679

1,136

1,612

881

0

0

0

Accounts payable

1,312

-360

-1,068

-2,438

-7,543

-10,375

-7,979

-14,697

-8,714

-5,502

-12,596

-5,253

-5,496

-7,326

-642

303

-425

1,363

371

-1,256

-1,911

-109

-959

1,556

2,159

483

0

0

0

Accrued liabilities

-6,899

-5,093

-546

3,317

4,385

3,252

814

-2,952

38

509

3,860

6,861

4,696

3,069

3,702

3,039

1,989

2,742

2,369

1,884

1,638

696

954

1,144

995

2,947

0

0

0

Other liabilities, net

-

-

-

-

-

-4,209

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred income

-167

-107

0

0

0

-

-

-

-

-

-

-

-

-1,639

-1,497

-2,448

-1,735

-250

123

442

-394

572

-418

1,106

1,543

587

0

0

0

Net cash used in operating activities from continuing operations

-7,121

-7,163

-18,551

-20,301

-25,584

-32,119

0

0

0

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-16,549

-19,483

-23,215

-20,970

-20,777

-14,060

-11,115

-11,369

-5,619

0

0

0

Cash flows from investing activities
Purchases of property and equipment

2,121

1,658

1,195

2,481

4,910

5,350

5,444

1,756

576

1,295

-760

2,171

1,426

856

3,310

3,456

2,948

3,425

2,913

3,127

3,641

3,014

2,834

2,744

2,138

1,809

0

0

0

Purchases of intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

354

0

0

0

-

-

-

-

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-312

-200

-200

-200

-57

-57

-129

-129

-225

0

0

0

Net cash used in investing activities from continuing operations

-2,121

-1,658

-1,195

-2,481

-4,910

-5,350

0

0

0

-

-

-

-

-

-

0

-2,845

-

-3,095

-5,024

-5,494

-5,027

0

0

0

-

-

-

-

Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Cash flows from financing activities
Proceeds from issuance of ordinary shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

53,763

0

0

0

-

-

-

-

-

-

-

-

Proceeds from exercise of share options

2,237

4,035

4,470

5,759

4,956

3,241

2,763

1,067

586

561

556

372

124

76

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Payments of tax withheld on exercises of options and vesting of restricted share units

234

224

342

273

372

383

274

274

182

212

0

0

186

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Repurchases of ordinary shares

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on capital lease

-

-

-

-

-

60

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in loans payable

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of preferred ordinary shares

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,942

0

0

0

Proceeds from exercise of share options and warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

18

14

15

22

0

0

0

Payments on loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

99

-

133

169

165

165

6,147

6,101

6,089

6,068

0

0

0

Net cash provided by (used in) financing activities from continuing operations

-12,721

-3,181

-31,305

-26,641

-27,562

-29,307

0

0

0

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash flows of continuing operations

-21,963

-12,002

-51,051

-49,423

-58,056

-66,776

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from discontinued operations
Net operating cash flows provided by discontinued operations

0

-

-

-

-

14,729

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net investing cash flows used in discontinued operations

-

-

-

-

-

156,218

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net financing cash flows used in discontinued operations

-

-

-

-

-

-48

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash flows of discontinued operations

0

-

-

-

-

170,899

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

53,661

53,644

53,608

53,622

-151

63,174

63,216

67,738

70,699

0

0

0

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

-1,217

428

-1,581

-1,257

-1,032

-1,711

-1,042

-541

398

451

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net decrease in cash, cash equivalents, and restricted cash

-23,033

-11,574

114,026

120,928

112,172

102,412

2,413

29,550

34,113

31,222

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Effect of exchange rate changes on cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,406

-1,231

-509

-440

-590

-774

-761

-374

573

2,075

1,845

603

0

0

0

Net increase (decrease) in cash and cash equivalents, excluding restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-51,159

-26,405

-25,296

33,550

30,476

24,595

26,397

-26,329

44,972

51,339

56,005

63,916

0

0

0